United States securities and exchange commission logo June 2, 2021 Chris Chang Yu Chief Executive Officer AnPac Bio-Medical Science Co., Ltd. Suite 127, 2260 Clove Drive San Jose, CA 95128 Re: AnPac Bio-Medical Science Co., Ltd. Registration Statement on Form F-3 Filed May 28, 2021 File No. 333-256630 Dear Dr. Yu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: William S. Rosenstadt, Esq.